DELFI Diagnostics’ Post

View organization page for DELFI Diagnostics, graphic

15,570 followers

#DELFI is thrilled to attend the #WCLC24 in San Diego, September 7-10. Our Director of Medical Affairs, Dr. Lindsey C., will present two posters: Sunday, September 8: "P2.04A.01 FIRSTLUNG (L301): Cluster Randomized Trial Evaluating the Clinical Utility of DELFI's Blood-Based Lung Cancer Screening Test" - https://lnkd.in/ePJGHztE Monday, September 9: "P4.04C.07: Improving the Efficiency of Lung Cancer Screening Through a Blood-based Lung Cancer Screening Test Prior to Low-Dose CT" - https://lnkd.in/eesEbApA Other members of the DELFI team will attend #WCLC24 including Account Executives Allyson Perdue and Patra Glavin, VP of Market Access & Health Economics Chris Cisar, Medical Science Liaison Dr. Demetria Tennefoss and CMO Peter B.. If you want to learn more about partnering with DELFI to enhance lung cancer screening in your #healthsystem, please contact Allyson Perdue to schedule a meeting. #cancerresearch #lungcancer #cancerscreening #healthsystems #healthcaresystems #liquidbiopsy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics